The contribution of amphetamine metabolites of (−)-deprenyl to its antiparkinsonian properties
Elsworth J, Sandler M, Lees A, Ward C, Stern G. The contribution of amphetamine metabolites of (−)-deprenyl to its antiparkinsonian properties. Journal Of Neural Transmission 1982, 54: 105-110. PMID: 6809891, DOI: 10.1007/bf01249283.Peer-Reviewed Original ResearchMeSH KeywordsAmphetamineDouble-Blind MethodDrug Therapy, CombinationHumansHydrogen-Ion ConcentrationLevodopaMethamphetamineMiddle AgedParkinson DiseasePhenethylaminesSelegiline